Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B1 | P14061 | 3/20 | 0.51 |
| ▸ | HSD17B2 | P37059 | 3/20 | 0.51 |
| ▸ | CA12 | O43570 | 2/20 | 0.48 |
| ▸ | CA1 | P00915 | 2/20 | 0.48 |
| ▸ | CA2 | P00918 | 2/20 | 0.48 |
| ▸ | CA9 | Q16790 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.45 |
| ▸ | MAPT | P10636 | 4/20 | 0.45 |
| ▸ | HPGD | P15428 | 4/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.45 |
| ▸ | TP53 | P04637 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.45 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.45 |
| ▸ | RELA | Q04206 | 1/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17754448 | 1.00 | HSD17B1 (0.51) | HSD17B1HSD17B2CA12CA1CA2 | |
| SCHEMBL17754450 | 0.97 | HSD17B1 (0.49) | HSD17B1HSD17B2CA12CA1CA2 | |
| SCHEMBL23633475 | 0.97 | HSD17B1 (0.47) | HSD17B1HSD17B2CA12CA1CA2 | |
| SCHEMBL27455958 | 0.97 | HSD17B1 (0.47) | HSD17B1HSD17B2CA12CA1CA2 | |
| SCHEMBL27455831 | 0.95 | CA12 (0.48) | HSD17B1HSD17B2CA12CA1CA2 | |
| SCHEMBL23633512 | 0.95 | HSD17B1 (0.49) | HSD17B1HSD17B2CA12CA1CA2 | |
| SCHEMBL18965493 | 0.95 | HSD17B1 (0.49) | HSD17B1HSD17B2CA12CA1CA2 | |
| SCHEMBL17655845 | 0.94 | MEN1 (0.54) | HSD17B1HSD17B2CA12CA1CA2 | |
| SCHEMBL23633698 | 0.94 | HSD17B1 (0.47) | HSD17B1HSD17B2CA12CA1CA2 | |
| SCHEMBL17655913 | 0.94 | MEN1 (0.54) | HSD17B1HSD17B2CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210050528-A1 | ORGANIC LIGHT EMITTING DIODE | LG CHEM, LTD. (KR) | 2021-02-18 | — | — | US | disclosed |
| US-10454056-B1 | Organic light emitting device | LG CHEM, LTD. (KR) | 2019-10-22 | — | — | US | disclosed |
| US-20190312223-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2019-10-10 | — | — | US | disclosed |
| US-9882146-B2 | Heterocyclic compound and organic electronic element containing same | LG CHEM, LTD. (KR) | 2018-01-30 | — | — | US | disclosed |
| US-9882146-B2 | Heterocyclic compound and organic electronic element containing same | LG CHEM, LTD. (KR) | 2018-01-30 | — | — | US | disclosed |
| US-20160218298-A1 | HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC ELEMENT CONTAINING SAME | LG CHEM, LTD. (KR) | 2016-07-28 | — | — | US | disclosed |
| US-20160218298-A1 | HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC ELEMENT CONTAINING SAME | LG CHEM, LTD. (KR) | 2016-07-28 | — | — | US | disclosed |
| US-9391281-B2 | Heterocyclic compound and organic electronic element containing same | LG CHEM, LTD. (KR) | 2016-07-12 | — | — | US | disclosed |
| US-9391281-B2 | Heterocyclic compound and organic electronic element containing same | LG CHEM, LTD. (KR) | 2016-07-12 | — | — | US | disclosed |
| US-20150162543-A1 | HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC ELEMENT CONTAINING SAME | LG CHEM, LTD. (KR) | 2015-06-11 | — | — | US | disclosed |
| US-20150162543-A1 | HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC ELEMENT CONTAINING SAME | LG CHEM, LTD. (KR) | 2015-06-11 | — | — | US | disclosed |
| EP-2873667-A1 | HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC ELEMENT CONTAINING SAME | LG Chem, Ltd. (KR) | 2015-05-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160218298-A1 | HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC ELEMENT CONTAINING SAME | ESR1, ERCC1, NFE2L2 | HSD17B1 3033/4885HSD17B2 1687/4885CA12 1040/4885 |
| US-20150162543-A1 | HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC ELEMENT CONTAINING SAME | ESR1, ERCC1, NFE2L2 | HSD17B1 3033/4885HSD17B2 1687/4885CA12 1040/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.